Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Wave Life Sciences’s reported figures.
Plus components not separately reported this period.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
FAQ
- What is Wave Life Sciences's EBIT?
- Wave Life Sciences (WVE) reported EBIT of -$73.8M in Q2 2026.
- How has Wave Life Sciences's EBIT changed year-over-year?
- Wave Life Sciences's EBIT decreased by 39.9% year-over-year, from -$52.76M to -$73.8M.
- What is the long-term trend for Wave Life Sciences's EBIT?
- Over 3 years (2021 to 2025), Wave Life Sciences's EBIT has grown at a 19.2% compound annual growth rate (CAGR), from -$127.02M to -$215.38M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Wave Life Sciences's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude